🟢 Precigen is trading 4.3% up today with no company-specific catalyst identified

Precigen is trading 4.29% higher at $8.39; no company-specific catalyst dated September 30 was found, while broader-market gains may be supportive. - The Nasdaq is also higher. - Earlier momentum included the FDA’s September 21 AdenoVerse platform designation and B. Riley’s September 25 Buy initiation; both predate this session and do not establish the cause of today’s move.